Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Allogeneic haematopoietic stem-cell transplantation with reduced intensity conditioning for advanced stage Hodgkin's lymphoma in Sweden: high incidence of post transplant lymphoproliferative disorder.
Johansson JE, Remberger M, Lazarevic VLj, Hallböök H, Wahlin A, Kimby E, Juliusson G, Omar H, Hägglund H. Johansson JE, et al. Bone Marrow Transplant. 2011 Jun;46(6):870-5. doi: 10.1038/bmt.2010.238. Epub 2010 Oct 18. Bone Marrow Transplant. 2011. PMID: 20956959
Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?
Machaczka M, Johansson JE, Remberger M, Hallböök H, Malm C, Lazarevic VLj, Wahlin A, Omar H, Juliusson G, Kimby E, Hägglund H. Machaczka M, et al. Among authors: johansson je. Leuk Lymphoma. 2012 Sep;53(9):1699-705. doi: 10.3109/10428194.2012.666661. Epub 2012 Mar 16. Leuk Lymphoma. 2012. PMID: 22335529
High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse.
Machaczka M, Johansson JE, Remberger M, Hallböök H, Lazarevic VLj, Wahlin BE, Omar H, Wahlin A, Juliusson G, Kimby E, Hägglund H. Machaczka M, et al. Among authors: johansson je. Med Oncol. 2013 Dec;30(4):762. doi: 10.1007/s12032-013-0762-x. Epub 2013 Nov 9. Med Oncol. 2013. PMID: 24214180
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R, Askmark H, Svenningsson A, Andersen O, Axelson HW, Strömberg U, Wahlin A, Isaksson C, Johansson JE, Hägglund H. Press R, et al. Among authors: johansson je. J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):618-24. doi: 10.1136/jnnp-2013-306014. Epub 2013 Nov 21. J Neurol Neurosurg Psychiatry. 2014. PMID: 24262917
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J. Burman J, et al. Among authors: johansson je. J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19. J Neurol Neurosurg Psychiatry. 2014. PMID: 24554104
Short-term side effects and attitudes towards second donation: A comparison of related and unrelated haematopoietic stem cell donors.
Pahnke S, Larfors G, Axdorph-Nygell U, Fischer-Nielsen A, Haastrup E, Heldal D, Itälä-Remes M, Johansson JE, Kauppila M, Lenhoff S, Ljungman P, Niittyvuopio R, Sandstedt A, Hägglund H. Pahnke S, et al. Among authors: johansson je. J Clin Apher. 2018 Jun;33(3):226-235. doi: 10.1002/jca.21576. Epub 2017 Aug 18. J Clin Apher. 2018. PMID: 28833474
Cancer incidence in healthy Swedish peripheral blood stem cell donors.
Pahnke S, Nygell UA, Johansson JE, Kisch A, Ljungman P, Sandstedt A, Hägglund H, Larfors G. Pahnke S, et al. Among authors: johansson je. Bone Marrow Transplant. 2022 May;57(5):795-802. doi: 10.1038/s41409-022-01617-6. Epub 2022 Mar 7. Bone Marrow Transplant. 2022. PMID: 35256742 Free PMC article.
234 results